BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20524930)

  • 1. Aurora A and B kinases--targets of novel anticancer drugs.
    Libertini S; Abagnale A; Passaro C; Botta G; Portella G
    Recent Pat Anticancer Drug Discov; 2010 Nov; 5(3):219-41. PubMed ID: 20524930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora-B kinase inhibitors for cancer chemotherapy.
    Yeung SC; Gully C; Lee MH
    Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora kinase inhibitors as anticancer molecules.
    Katayama H; Sen S
    Biochim Biophys Acta; 2010; 1799(10-12):829-39. PubMed ID: 20863917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurora kinases: new targets for cancer therapy.
    Carvajal RD; Tse A; Schwartz GK
    Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting aurora kinases in cancer treatment.
    Kelly KR; Ecsedy J; Mahalingam D; Nawrocki ST; Padmanabhan S; Giles FJ; Carew JS
    Curr Drug Targets; 2011 Dec; 12(14):2067-78. PubMed ID: 21777198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system.
    Pérez Fidalgo JA; Roda D; Roselló S; Rodríguez-Braun E; Cervantes A
    Clin Transl Oncol; 2009 Dec; 11(12):787-98. PubMed ID: 20045785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on aurora kinase inhibitors in gynecologic malignancies.
    Tao X; Chon HS; Fu S; Kavanagh JJ; Hu W
    Recent Pat Anticancer Drug Discov; 2008 Nov; 3(3):162-77. PubMed ID: 18991785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora kinase inhibitors: progress towards the clinic.
    Kollareddy M; Zheleva D; Dzubak P; Brahmkshatriya PS; Lepsik M; Hajduch M
    Invest New Drugs; 2012 Dec; 30(6):2411-32. PubMed ID: 22350019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora kinase inhibitors as anti-cancer therapy.
    Lok W; Klein RQ; Saif MW
    Anticancer Drugs; 2010 Apr; 21(4):339-50. PubMed ID: 20016367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target validation and biomarker identification in oncology : the example of aurora kinases.
    Colombo R; Moll J
    Mol Diagn Ther; 2008; 12(2):71-6. PubMed ID: 18422371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora B: a new prognostic marker and therapeutic target in cancer.
    Portella G; Passaro C; Chieffi P
    Curr Med Chem; 2011; 18(4):482-96. PubMed ID: 21143115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
    Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
    Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a future for Aurora kinase inhibitors for anticancer therapy?
    Carpinelli P; Moll J
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danusertib, an aurora kinase inhibitor.
    Meulenbeld HJ; Mathijssen RH; Verweij J; de Wit R; de Jonge MJ
    Expert Opin Investig Drugs; 2012 Mar; 21(3):383-93. PubMed ID: 22242557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Aurora kinase inhibitor patents.
    Coumar MS; Cheung CH; Chang JY; Hsieh HP
    Expert Opin Ther Pat; 2009 Mar; 19(3):321-56. PubMed ID: 19441907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 - 2013).
    Cheung CH; Sarvagalla S; Lee JY; Huang YC; Coumar MS
    Expert Opin Ther Pat; 2014 Sep; 24(9):1021-38. PubMed ID: 24965505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Aurora-A inhibitors in cancer therapy.
    Agnese V; Bazan V; Fiorentino FP; Fanale D; Badalamenti G; Colucci G; Adamo V; Santini D; Russo A
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi47-52. PubMed ID: 17591831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacodynamic model of Aurora kinase inhibitors in the spindle assembly checkpoint.
    Mistry HB; MacCallum DE; Jackson RC; Chaplain MA; Davidson FA
    Front Biosci (Landmark Ed); 2010 Jan; 15(1):249-58. PubMed ID: 20036819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The research progress of Aurora-B kinase and its inhibitors].
    Dong DD; Xiao YY; Liu W; Zhou HG; Yang C
    Yao Xue Xue Bao; 2013 Apr; 48(4):457-65. PubMed ID: 23833930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurora kinase family: a new target for anticancer drug.
    Macarulla T; Ramos FJ; Tabernero J
    Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):114-22. PubMed ID: 18537754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.